Alexion Pharmaceuticals Inc. (ALXN) Release: Data From Investigator-Initiated Phase 2 Study of Eculizumab (Soliris®) in Patients With Severe Relapsing Neuromyelitis Optica (NMO) Presented at the American Neurological Association Annual Meeting
10/9/2012 9:39:04 AM
More...
|
AVANIR Pharmaceuticals (AVNR) Presents Detailed Zenvia Confirmatory Phase III Results in Late-Breaker Session at American Neurological Association Meeting
10/13/2009 11:46:41 AM
More...
|
AVANIR Pharmaceuticals (AVNR) to Present Pivotal Zenvia Phase III Data at American Neurological Association and World Congress on Controversies in Neurology Annual Meetings
10/6/2009 8:14:12 AM
More...
|
AVANIR Pharmaceuticals (AVNR) Presents Data At American Neurological Association Annual Meeting
9/24/2008 10:00:29 AM
More...
|
Halozyme Therapeutics, Inc. (HTI) Presents Novel Stroke Data At The 2005 American Neurological Association Annual Meeting
10/19/2005 5:12:55 PM
More...
|
Prestwick Pharmaceuticals, Inc. Release: Pivotal Phase III Data Of Tetrabenazine For The Treatment Of Chorea Associated With Huntington's Disease To Be Presented At American Neurological Association (ANA) Annual Meeting
10/19/2005 5:11:23 PM
More...
|
Researchers Identify Critical Link In Lead-Induced Brain Swelling
10/19/2005 5:10:31 PM
More...
|